Heat Biologics Z Score

HTBX -  USA Stock  

USD 4.22  0.27  6.01%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Please check Heat Biologics Piotroski F Score and Heat Biologics Valuation analysis.

Heat Biologics Z Score 

 
Refresh
Heat Biologics Invested Capital is fairly stable at the moment as compared to the past year. Heat Biologics reported Invested Capital of 109.88 Million in 2020. Invested Capital Average is likely to rise to about 68.4 M in 2021, whereas Capital Expenditure is likely to drop (344.6 K) in 2021. Heat Biologics Gross Profit is fairly stable at the moment as compared to the past year. Heat Biologics reported Gross Profit of 2.95 Million in 2020. Interest Expense is likely to rise to about 681.7 K in 2021, whereas Consolidated Income is likely to drop (27.1 M) in 2021.

Heat Biologics Z Score Analysis

Heat Biologics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2018 2019 2020 2021 (projected)
Current Assets28.71 M15.21 M113.79 M122.78 M
Total Assets37.76 M25.96 M124.19 M134 M
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis

Current Heat Biologics Z Score

    
  19.2  
Most of Heat Biologics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heat Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

Heat Biologics Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Heat Biologics is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Heat Biologics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heat Biologics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heat Biologics' interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

According to the company's disclosures, Heat Biologics has a Z Score of 19.2. This is 184.44% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The z score for all United States stocks is 120.18% lower than that of the firm.

Heat Biologics Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heat Biologics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heat Biologics could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics of similar companies.
Heat Biologics is currently under evaluation in z score category among related companies.

Heat Biologics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Heat Biologics from analyzing Heat Biologics' financial statements. These drivers represent accounts that assess Heat Biologics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Heat Biologics' important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Average Assets10.02 M16 M31.75 M28.5 M87.47 M94.38 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(11.89 M)(12.52 M)(16.48 M)(19.7 M)(25.62 M)(26.3 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(11.89 M)(12.52 M)(16.48 M)(19.7 M)(25.62 M)(26.3 M)
Earnings before Tax(12.57 M)(12.65 M)(16.72 M)(19.97 M)(26.05 M)(26.74 M)
Average Equity6.12 M9.41 M22.51 M19.78 M78.13 M84.3 M
Enterprise Value14.67 M9.34 M1.73 M6.85 M99.4 M107.25 M
Free Cash Flow(13.57 M)(6.46 M)(22.31 M)(12.99 M)(22.36 M)(22.95 M)
Invested Capital(712.27 K)(2.17 M)8.2 M8.56 M109.88 M118.55 M
Invested Capital Average1.05 M1.35 M3.07 M9.05 M63.4 M68.4 M
Market Capitalization20.42 M13.7 M22.79 M16.22 M122.4 M132.06 M
Tangible Asset Value8.9 M18 M35.57 M24.5 M122.74 M132.43 M
Working Capital6.67 M1.41 M23.84 M6.77 M110.14 M118.83 M

Heat Biologics Fundamentals

About Heat Biologics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heat Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heat Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heat Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patients immune system against cancer through T-cell activation and expansion. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina. Heat Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Heat Biologics Investors Sentiment

The influence of Heat Biologics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Heat Biologics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Heat Biologics Implied Volatility

    
  167.8  
Heat Biologics' implied volatility exposes the market's sentiment of Heat Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Heat Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Heat Biologics stock will not fluctuate a lot when Heat Biologics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heat Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heat Biologics' short interest history, or implied volatility extrapolated from Heat Biologics options trading.

Current Sentiment - HTBX

Heat Biologics Investor Sentiment

Most of Macroaxis users are currently bullish on Heat Biologics. What is your judgment towards investing in Heat Biologics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Heat Biologics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Heat Biologics Piotroski F Score and Heat Biologics Valuation analysis. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Heat Biologics Stock analysis

When running Heat Biologics price analysis, check to measure Heat Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heat Biologics is operating at the current time. Most of Heat Biologics' value examination focuses on studying past and present price action to predict the probability of Heat Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Heat Biologics' price. Additionally, you may evaluate how the addition of Heat Biologics to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Heat Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heat Biologics. If investors know Heat Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heat Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Heat Biologics is measured differently than its book value, which is the value of Heat Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Heat Biologics' value that differs from its market value or its book value, called intrinsic value, which is Heat Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heat Biologics' market value can be influenced by many factors that don't directly affect Heat Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heat Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Heat Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heat Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.